Browse RMM Directory A-Z

Dabigatran Krka Prescriber Guide for primary prevention of venous thromboembolic events (VTE) following elective total hip or knee replacement surgery

${pdf_link}$

Dabigatran Prescriber Guide - paediatric use

Prescriber guide for paediatric use

${pdf_link}$

Dabigatran Prescriber Guide for prevention of VTE

Prescriber Guide for prevention of VTE

${pdf_link}$

Dabigatran Prescriber Guide for stroke prevention

Prescriber Guide for stroke prevention

${pdf_link}$

Dabigatran Etexilate Paediatric - Guide

This guide provides recommendations for the use of dabigatran etexilate in the paediatric population in order to minimise the risk of bleeding

${pdf_link}$

Dabigatran Etexilate Stroke - Guide

This guide provides recommendations for the use of dabigatran in order to minimise the risk of bleeding

${pdf_link}$

Dabigatran Etexilate Hip, Knee - Guide

This guide provides recommendations for the use of dabigatran in order to minimise the risk of bleeding

${pdf_link}$

Dabigatran Etexilate- Patient Alert Card

Dabigatran etexilate Information for Patients / Caregivers of paediatric patients

${pdf_link}$

Patient Alert Card

Information about the potential risk of bleeding during treatment with dabigatran etexilate and guidance on how to manage that risk.

${pdf_link}$

Prescriber Guide for paediatric use

Indication
Contraindications
Dosing Special patient populations potentially at high risk of bleeding
Perioperative management
Coagulation tests and their interpretation
Overdose
Management of bleeding complications
Patient Alert Card and counselling

${pdf_link}$

Prescriber Guide for stroke prevention in atrial fibrillation and treatment and prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults

Indications
Contraindications
Perioperative management
Dosing
Special patient populations potentially at higher risk of bleeding
Coagulation tests and their interpretation
Overdose
Management of bleeding complications
Patient Alert Card and counselling

${pdf_link}$

Prescriber Guide for venous thromboembolic events (VTE) following elective total hip or knee replacement surgery

Indication
Contraindications
Dosing
Special patient populations potentially at high risk of bleeding
Coagulation tests and their interpretation
Overdose
Management of bleeding complications
Dabigatran etexilate Patient Alert Card and counselling

${pdf_link}$

Dabigatran etexilate- Patient Alert Card

Patient Alert card

${pdf_link}$

Dabigatran etexilate-Prescriber Guide (deep vein thrombosis & pulmonary embolism)

${pdf_link}$

Dabigatran etexilate-Prescriber Guide (paediatric use)

${pdf_link}$

Dabigatran etexilate-Prescriber Guide (prevention of venous thromboembolic events)

${pdf_link}$

Pradaxa (dabigatran etexilate) coated granules Patient Alert Card

Every patient prescribed Pradaxa in the medication package will receive a Patient Alert Card. As the card contains important information the patient should be instructed to carry the patient alert card at all times and present it when seeing a health care professional. The patient should be counselled about the need for compliance and signs of bleeding and when to seek medical attention.

${pdf_link}$

Pradaxa (dabigatran etexilate) Patient Alert Card

Every patient prescribed Pradaxa will receive a Patient Alert Card in the medication pack. As the card contains important information the patient should be instructed to carry the patient alert card at all times and present it when seeing a health care professional. The patient should be counselled about the need for compliance and signs of bleeding and when to seek medical attention.

${pdf_link}$

Pradaxa (dabigatran etexilate) Prescriber guide for primary prevention of venous thromboembolic events (VTE) following elective hip or knee replacement surgery

Risk Minimisation Materials

Dabigatran

Biocon Pharma UK Limited

Genus Pharmaceuticals

Krka UK Ltd

Zentiva

Dabigatran etexilate

Glenmark Pharmaceuticals Europe Ltd

Laboratorios Liconsa, S.A.

Sandoz Limited

Pradaxa

Boehringer Ingelheim Limited

You are trying to reach document intended for healthcare professionals only.